ZEPLAST- PED: ZEro_PLASma Trial in Small Infants Undergoing Cardiac Surgery Randomized Controlled Pilot Phase II Study
Latest Information Update: 06 Sep 2023
Price :
$35 *
At a glance
- Drugs Fibrinogen (Primary) ; Prothrombin complex concentrate (Primary) ; Plasma; Protamine sulfate
- Indications Afibrinogenaemia; Hypoprothrombinaemia; Postoperative haemorrhage
- Focus Therapeutic Use
- Acronyms ZEPLAST-PED
- 28 Oct 2021 Status changed from recruiting to discontinued.
- 01 Feb 2021 Planned End Date changed from 9 Oct 2020 to 30 Jun 2021.
- 01 Feb 2021 Planned primary completion date changed from 10 Aug 2020 to 31 May 2021.